High dose intravenous methylprednisolone for Kassabach-Merritt syndrome
- 1 February 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 148 (5) , 403-405
- https://doi.org/10.1007/bf00595897
Abstract
Kassabach-Merritt syndrome involving the sternum in a 2-month-old child is described. Treatment with high dose intravenous methylprednisolone resulted in normalization of the platelet count and disappearence of haemangioma.Keywords
This publication has 23 references indexed in Scilit:
- High‐dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpuraEuropean Journal of Haematology, 1989
- High dose intravenous methylprednisolone in treatment of recessive osteopetrosis.Archives of Disease in Childhood, 1987
- Cyclophosphamide therapy in life-threatening vascular tumorsThe Journal of Pediatrics, 1986
- Picture of the MonthArchives of Pediatrics & Adolescent Medicine, 1986
- Kasabach–Merritt Syndrome Treated by Therapeutic Embolization with Polyvinyl AlcoholJournal of Pediatric Hematology/Oncology, 1986
- Treatment of Severe Coagulopathy in the Kasabach-Merritt Syndrome with Aminocaproic Acid and CryoprecipitateNew England Journal of Medicine, 1985
- High-Dose Intravenous Corticosteroid for a Patient with Diamond-Blackfan Syndrome Refractory to Classical Prednisone TreatmentActa Haematologica, 1984
- Letter: Bronchial lability in cystic fibrosis.Archives of Disease in Childhood, 1975
- Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemiaThe American Journal of Medicine, 1969
- Effects of Corticosteroids on Coagulation of the BloodNature, 1962